The global Gestational Diabetes Treatment market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
Report Overview
Gestational diabetes can be defined as a type of diabetes that affects pregnant women.It is usually a temporary condition which develops during pregnancy and subsides after the birth of the baby.However, there are possibilities that diabetes may return in the later stages of life as type II diabetes mellitus.It is the inability of insulin to absorb the sugars consumed as part of the meal.It may be caused due to insulin resistance in a woman s body because of increasing levels of placental hormones being produced to sustain the development of the fetus.This condition starts when the female body is not able to make and use required amounts of insulin needed in pregnancy, resulting in a build-up of sugar in the bloodstream causing hyperglycemia.
This report provides a deep insight into the global Gestational Diabetes Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gestational Diabetes Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gestational Diabetes Treatment market in any manner.
Global Gestational Diabetes Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Biocon Limited
- Eli Lilly
- Novo Nordisk
- Boehringer Ingelheim GmbH
- Sanofi S.A.
- Sun Pharmaceutical Industries Limited
- Merck
- Novartis
- Adocia
- Peptron
- AstraZeneca plc
- Pfizer, Inc
- Takeda Pharmaceutical Company Ltd
- Abbott
- Antares Pharma
- INJEX Pharma AG
- Daiichi Sankyo
Market Segmentation (by Type)
- Insulin
- SGLT-2 Inhibitors
- Alpha-glucosidase Inhibitors
- Others
Market Segmentation (by Application)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gestational Diabetes Treatment Market
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical
scope of the report, market division standards, and market research methods.
Chapter 2 is an executive
summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gestational Diabetes Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gestational Diabetes Treatment
1.2 Key Market Segments
1.2.1 Gestational Diabetes Treatment Segment by Type
1.2.2 Gestational Diabetes Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gestational Diabetes Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Gestational Diabetes Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gestational Diabetes Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gestational Diabetes Treatment Market Competitive Landscape
3.1 Global Gestational Diabetes Treatment Sales by Manufacturers (2019-2024)
3.2 Global Gestational Diabetes Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Gestational Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gestational Diabetes Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gestational Diabetes Treatment Sales Sites, Area Served, Product Type
3.6 Gestational Diabetes Treatment Market Competitive Situation and Trends
3.6.1 Gestational Diabetes Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gestational Diabetes Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Gestational Diabetes Treatment Industry Chain Analysis
4.1 Gestational Diabetes Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gestational Diabetes Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Gestational Diabetes Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gestational Diabetes Treatment Sales Market Share by Type (2019-2024)
6.3 Global Gestational Diabetes Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Gestational Diabetes Treatment Price by Type (2019-2024)
7 Gestational Diabetes Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gestational Diabetes Treatment Market Sales by Application (2019-2024)
7.3 Global Gestational Diabetes Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Gestational Diabetes Treatment Sales Growth Rate by Application (2019-2024)
8 Gestational Diabetes Treatment Market Segmentation by Region
8.1 Global Gestational Diabetes Treatment Sales by Region
8.1.1 Global Gestational Diabetes Treatment Sales by Region
8.1.2 Global Gestational Diabetes Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Gestational Diabetes Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gestational Diabetes Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gestational Diabetes Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gestational Diabetes Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gestational Diabetes Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Biocon Limited
9.1.1 Biocon Limited Gestational Diabetes Treatment Basic Information
9.1.2 Biocon Limited Gestational Diabetes Treatment Product Overview
9.1.3 Biocon Limited Gestational Diabetes Treatment Product Market Performance
9.1.4 Biocon Limited Business Overview
9.1.5 Biocon Limited Gestational Diabetes Treatment SWOT Analysis
9.1.6 Biocon Limited Recent Developments
9.2 Eli Lilly
9.2.1 Eli Lilly Gestational Diabetes Treatment Basic Information
9.2.2 Eli Lilly Gestational Diabetes Treatment Product Overview
9.2.3 Eli Lilly Gestational Diabetes Treatment Product Market Performance
9.2.4 Eli Lilly Business Overview
9.2.5 Eli Lilly Gestational Diabetes Treatment SWOT Analysis
9.2.6 Eli Lilly Recent Developments
9.3 Novo Nordisk
9.3.1 Novo Nordisk Gestational Diabetes Treatment Basic Information
9.3.2 Novo Nordisk Gestational Diabetes Treatment Product Overview
9.3.3 Novo Nordisk Gestational Diabetes Treatment Product Market Performance
9.3.4 Novo Nordisk Gestational Diabetes Treatment SWOT Analysis
9.3.5 Novo Nordisk Business Overview
9.3.6 Novo Nordisk Recent Developments
9.4 Boehringer Ingelheim GmbH
9.4.1 Boehringer Ingelheim GmbH Gestational Diabetes Treatment Basic Information
9.4.2 Boehringer Ingelheim GmbH Gestational Diabetes Treatment Product Overview
9.4.3 Boehringer Ingelheim GmbH Gestational Diabetes Treatment Product Market Performance
9.4.4 Boehringer Ingelheim GmbH Business Overview
9.4.5 Boehringer Ingelheim GmbH Recent Developments
9.5 Sanofi S.A.
9.5.1 Sanofi S.A. Gestational Diabetes Treatment Basic Information
9.5.2 Sanofi S.A. Gestational Diabetes Treatment Product Overview
9.5.3 Sanofi S.A. Gestational Diabetes Treatment Product Market Performance
9.5.4 Sanofi S.A. Business Overview
9.5.5 Sanofi S.A. Recent Developments
9.6 Sun Pharmaceutical Industries Limited
9.6.1 Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Basic Information
9.6.2 Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Product Overview
9.6.3 Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Product Market Performance
9.6.4 Sun Pharmaceutical Industries Limited Business Overview
9.6.5 Sun Pharmaceutical Industries Limited Recent Developments
9.7 Merck
9.7.1 Merck Gestational Diabetes Treatment Basic Information
9.7.2 Merck Gestational Diabetes Treatment Product Overview
9.7.3 Merck Gestational Diabetes Treatment Product Market Performance
9.7.4 Merck Business Overview
9.7.5 Merck Recent Developments
9.8 Novartis
9.8.1 Novartis Gestational Diabetes Treatment Basic Information
9.8.2 Novartis Gestational Diabetes Treatment Product Overview
9.8.3 Novartis Gestational Diabetes Treatment Product Market Performance
9.8.4 Novartis Business Overview
9.8.5 Novartis Recent Developments
9.9 Adocia
9.9.1 Adocia Gestational Diabetes Treatment Basic Information
9.9.2 Adocia Gestational Diabetes Treatment Product Overview
9.9.3 Adocia Gestational Diabetes Treatment Product Market Performance
9.9.4 Adocia Business Overview
9.9.5 Adocia Recent Developments
9.10 Peptron
9.10.1 Peptron Gestational Diabetes Treatment Basic Information
9.10.2 Peptron Gestational Diabetes Treatment Product Overview
9.10.3 Peptron Gestational Diabetes Treatment Product Market Performance
9.10.4 Peptron Business Overview
9.10.5 Peptron Recent Developments
9.11 AstraZeneca plc
9.11.1 AstraZeneca plc Gestational Diabetes Treatment Basic Information
9.11.2 AstraZeneca plc Gestational Diabetes Treatment Product Overview
9.11.3 AstraZeneca plc Gestational Diabetes Treatment Product Market Performance
9.11.4 AstraZeneca plc Business Overview
9.11.5 AstraZeneca plc Recent Developments
9.12 Pfizer, Inc
9.12.1 Pfizer, Inc Gestational Diabetes Treatment Basic Information
9.12.2 Pfizer, Inc Gestational Diabetes Treatment Product Overview
9.12.3 Pfizer, Inc Gestational Diabetes Treatment Product Market Performance
9.12.4 Pfizer, Inc Business Overview
9.12.5 Pfizer, Inc Recent Developments
9.13 Takeda Pharmaceutical Company Ltd
9.13.1 Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Basic Information
9.13.2 Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Product Overview
9.13.3 Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Product Market Performance
9.13.4 Takeda Pharmaceutical Company Ltd Business Overview
9.13.5 Takeda Pharmaceutical Company Ltd Recent Developments
9.14 Abbott
9.14.1 Abbott Gestational Diabetes Treatment Basic Information
9.14.2 Abbott Gestational Diabetes Treatment Product Overview
9.14.3 Abbott Gestational Diabetes Treatment Product Market Performance
9.14.4 Abbott Business Overview
9.14.5 Abbott Recent Developments
9.15 Antares Pharma
9.15.1 Antares Pharma Gestational Diabetes Treatment Basic Information
9.15.2 Antares Pharma Gestational Diabetes Treatment Product Overview
9.15.3 Antares Pharma Gestational Diabetes Treatment Product Market Performance
9.15.4 Antares Pharma Business Overview
9.15.5 Antares Pharma Recent Developments
9.16 INJEX Pharma AG
9.16.1 INJEX Pharma AG Gestational Diabetes Treatment Basic Information
9.16.2 INJEX Pharma AG Gestational Diabetes Treatment Product Overview
9.16.3 INJEX Pharma AG Gestational Diabetes Treatment Product Market Performance
9.16.4 INJEX Pharma AG Business Overview
9.16.5 INJEX Pharma AG Recent Developments
9.17 Daiichi Sankyo
9.17.1 Daiichi Sankyo Gestational Diabetes Treatment Basic Information
9.17.2 Daiichi Sankyo Gestational Diabetes Treatment Product Overview
9.17.3 Daiichi Sankyo Gestational Diabetes Treatment Product Market Performance
9.17.4 Daiichi Sankyo Business Overview
9.17.5 Daiichi Sankyo Recent Developments
10 Gestational Diabetes Treatment Market Forecast by Region
10.1 Global Gestational Diabetes Treatment Market Size Forecast
10.2 Global Gestational Diabetes Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gestational Diabetes Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Gestational Diabetes Treatment Market Size Forecast by Region
10.2.4 South America Gestational Diabetes Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gestational Diabetes Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Gestational Diabetes Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gestational Diabetes Treatment by Type (2025-2030)
11.1.2 Global Gestational Diabetes Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gestational Diabetes Treatment by Type (2025-2030)
11.2 Global Gestational Diabetes Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Gestational Diabetes Treatment Sales (K Units) Forecast by Application
11.2.2 Global Gestational Diabetes Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gestational Diabetes Treatment Market Size Comparison by Region (M USD)
Table 5. Global Gestational Diabetes Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gestational Diabetes Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gestational Diabetes Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gestational Diabetes Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gestational Diabetes Treatment as of 2022)
Table 10. Global Market Gestational Diabetes Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gestational Diabetes Treatment Sales Sites and Area Served
Table 12. Manufacturers Gestational Diabetes Treatment Product Type
Table 13. Global Gestational Diabetes Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gestational Diabetes Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gestational Diabetes Treatment Market Challenges
Table 22. Global Gestational Diabetes Treatment Sales by Type (K Units)
Table 23. Global Gestational Diabetes Treatment Market Size by Type (M USD)
Table 24. Global Gestational Diabetes Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Gestational Diabetes Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Gestational Diabetes Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Gestational Diabetes Treatment Market Size Share by Type (2019-2024)
Table 28. Global Gestational Diabetes Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gestational Diabetes Treatment Sales (K Units) by Application
Table 30. Global Gestational Diabetes Treatment Market Size by Application
Table 31. Global Gestational Diabetes Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Gestational Diabetes Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Gestational Diabetes Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Gestational Diabetes Treatment Market Share by Application (2019-2024)
Table 35. Global Gestational Diabetes Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Gestational Diabetes Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Gestational Diabetes Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Gestational Diabetes Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gestational Diabetes Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gestational Diabetes Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Gestational Diabetes Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gestational Diabetes Treatment Sales by Region (2019-2024) & (K Units)
Table 43. Biocon Limited Gestational Diabetes Treatment Basic Information
Table 44. Biocon Limited Gestational Diabetes Treatment Product Overview
Table 45. Biocon Limited Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Biocon Limited Business Overview
Table 47. Biocon Limited Gestational Diabetes Treatment SWOT Analysis
Table 48. Biocon Limited Recent Developments
Table 49. Eli Lilly Gestational Diabetes Treatment Basic Information
Table 50. Eli Lilly Gestational Diabetes Treatment Product Overview
Table 51. Eli Lilly Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Eli Lilly Business Overview
Table 53. Eli Lilly Gestational Diabetes Treatment SWOT Analysis
Table 54. Eli Lilly Recent Developments
Table 55. Novo Nordisk Gestational Diabetes Treatment Basic Information
Table 56. Novo Nordisk Gestational Diabetes Treatment Product Overview
Table 57. Novo Nordisk Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Novo Nordisk Gestational Diabetes Treatment SWOT Analysis
Table 59. Novo Nordisk Business Overview
Table 60. Novo Nordisk Recent Developments
Table 61. Boehringer Ingelheim GmbH Gestational Diabetes Treatment Basic Information
Table 62. Boehringer Ingelheim GmbH Gestational Diabetes Treatment Product Overview
Table 63. Boehringer Ingelheim GmbH Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Boehringer Ingelheim GmbH Business Overview
Table 65. Boehringer Ingelheim GmbH Recent Developments
Table 66. Sanofi S.A. Gestational Diabetes Treatment Basic Information
Table 67. Sanofi S.A. Gestational Diabetes Treatment Product Overview
Table 68. Sanofi S.A. Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Sanofi S.A. Business Overview
Table 70. Sanofi S.A. Recent Developments
Table 71. Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Basic Information
Table 72. Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Product Overview
Table 73. Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Sun Pharmaceutical Industries Limited Business Overview
Table 75. Sun Pharmaceutical Industries Limited Recent Developments
Table 76. Merck Gestational Diabetes Treatment Basic Information
Table 77. Merck Gestational Diabetes Treatment Product Overview
Table 78. Merck Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Merck Business Overview
Table 80. Merck Recent Developments
Table 81. Novartis Gestational Diabetes Treatment Basic Information
Table 82. Novartis Gestational Diabetes Treatment Product Overview
Table 83. Novartis Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Novartis Business Overview
Table 85. Novartis Recent Developments
Table 86. Adocia Gestational Diabetes Treatment Basic Information
Table 87. Adocia Gestational Diabetes Treatment Product Overview
Table 88. Adocia Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Adocia Business Overview
Table 90. Adocia Recent Developments
Table 91. Peptron Gestational Diabetes Treatment Basic Information
Table 92. Peptron Gestational Diabetes Treatment Product Overview
Table 93. Peptron Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Peptron Business Overview
Table 95. Peptron Recent Developments
Table 96. AstraZeneca plc Gestational Diabetes Treatment Basic Information
Table 97. AstraZeneca plc Gestational Diabetes Treatment Product Overview
Table 98. AstraZeneca plc Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. AstraZeneca plc Business Overview
Table 100. AstraZeneca plc Recent Developments
Table 101. Pfizer, Inc Gestational Diabetes Treatment Basic Information
Table 102. Pfizer, Inc Gestational Diabetes Treatment Product Overview
Table 103. Pfizer, Inc Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Pfizer, Inc Business Overview
Table 105. Pfizer, Inc Recent Developments
Table 106. Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Basic Information
Table 107. Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Product Overview
Table 108. Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Takeda Pharmaceutical Company Ltd Business Overview
Table 110. Takeda Pharmaceutical Company Ltd Recent Developments
Table 111. Abbott Gestational Diabetes Treatment Basic Information
Table 112. Abbott Gestational Diabetes Treatment Product Overview
Table 113. Abbott Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Abbott Business Overview
Table 115. Abbott Recent Developments
Table 116. Antares Pharma Gestational Diabetes Treatment Basic Information
Table 117. Antares Pharma Gestational Diabetes Treatment Product Overview
Table 118. Antares Pharma Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Antares Pharma Business Overview
Table 120. Antares Pharma Recent Developments
Table 121. INJEX Pharma AG Gestational Diabetes Treatment Basic Information
Table 122. INJEX Pharma AG Gestational Diabetes Treatment Product Overview
Table 123. INJEX Pharma AG Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. INJEX Pharma AG Business Overview
Table 125. INJEX Pharma AG Recent Developments
Table 126. Daiichi Sankyo Gestational Diabetes Treatment Basic Information
Table 127. Daiichi Sankyo Gestational Diabetes Treatment Product Overview
Table 128. Daiichi Sankyo Gestational Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Daiichi Sankyo Business Overview
Table 130. Daiichi Sankyo Recent Developments
Table 131. Global Gestational Diabetes Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Gestational Diabetes Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Gestational Diabetes Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Gestational Diabetes Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Gestational Diabetes Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Gestational Diabetes Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Gestational Diabetes Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Gestational Diabetes Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Gestational Diabetes Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Gestational Diabetes Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Gestational Diabetes Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Gestational Diabetes Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Gestational Diabetes Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Gestational Diabetes Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Gestational Diabetes Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Gestational Diabetes Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Gestational Diabetes Treatment Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Gestational Diabetes Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gestational Diabetes Treatment Market Size (M USD), 2019-2030
Figure 5. Global Gestational Diabetes Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Gestational Diabetes Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gestational Diabetes Treatment Market Size by Country (M USD)
Figure 11. Gestational Diabetes Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Gestational Diabetes Treatment Revenue Share by Manufacturers in 2023
Figure 13. Gestational Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gestational Diabetes Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gestational Diabetes Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gestational Diabetes Treatment Market Share by Type
Figure 18. Sales Market Share of Gestational Diabetes Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Gestational Diabetes Treatment by Type in 2023
Figure 20. Market Size Share of Gestational Diabetes Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Gestational Diabetes Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gestational Diabetes Treatment Market Share by Application
Figure 24. Global Gestational Diabetes Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Gestational Diabetes Treatment Sales Market Share by Application in 2023
Figure 26. Global Gestational Diabetes Treatment Market Share by Application (2019-2024)
Figure 27. Global Gestational Diabetes Treatment Market Share by Application in 2023
Figure 28. Global Gestational Diabetes Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gestational Diabetes Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gestational Diabetes Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gestational Diabetes Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gestational Diabetes Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gestational Diabetes Treatment Sales Market Share by Country in 2023
Figure 37. Germany Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gestational Diabetes Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gestational Diabetes Treatment Sales Market Share by Region in 2023
Figure 44. China Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gestational Diabetes Treatment Sales and Growth Rate (K Units)
Figure 50. South America Gestational Diabetes Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gestational Diabetes Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gestational Diabetes Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gestational Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gestational Diabetes Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gestational Diabetes Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gestational Diabetes Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gestational Diabetes Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Gestational Diabetes Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Gestational Diabetes Treatment Market Share Forecast by Application (2025-2030)
